A Randomized Controlled Trial of Exercise Training Among Men With Type 2-diabetes
NCT ID: NCT00666094
Last Updated: 2017-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2008-08-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Time Efficient Exercise in Type 2 Diabetes
NCT02340260
Effect of Exercise Frequency on Metabolic Control and Heart Function in Type 2 Diabetes
NCT02388113
Effects of Different Types of Exercise in Type 2 Diabetes
NCT01182948
Effects of Acute High Intensity Exercise Training on Cardiac Function in Type II Diabetes
NCT02998008
Effort During Resistance Training in Type 2 Diabetes
NCT06497842
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Therefore we randomized 26 men with type 2-diabetes to either an endurance training group or a strength training group. Both groups exercised three sessions per week for three months. The training was supervised.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
endurance training
supervised endurance training
Endurance training
supervised endurance training. Three sessions per week in three months.
strength training
Supervised strength training
strength training
Supervised strength training. Three sessions per week in three months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endurance training
supervised endurance training. Three sessions per week in three months.
strength training
Supervised strength training. Three sessions per week in three months.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male, 35-71 years
* Managing their diabetes through a lifestyle and/or the drug metformin only
* Able to participate in either of the exercise groups
Exclusion Criteria
* Uncontrolled hypertension
* Physical or cognitive disabilities that will interfere with participating in the exercise regimes.
* Trained consistently during the last six months.
35 Years
71 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Olavs Hospital
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liv B Augestad, PhD
Role: STUDY_DIRECTOR
National Taiwan Normal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NTNU
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Moe B, Augestad LB, Ã…svold BO, Flanders WD. Effects of aerobic versus resistance training on glycaemic control in men with type 2 diabetes. European Journal of Sports Science 11(5): 365-374, 2011
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
520073168
Identifier Type: OTHER
Identifier Source: secondary_id
520073168
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.